KR101007161B1 - 피부병 치료를 위한 아다팔렌의 용도 - Google Patents
피부병 치료를 위한 아다팔렌의 용도 Download PDFInfo
- Publication number
- KR101007161B1 KR101007161B1 KR1020047014228A KR20047014228A KR101007161B1 KR 101007161 B1 KR101007161 B1 KR 101007161B1 KR 1020047014228 A KR1020047014228 A KR 1020047014228A KR 20047014228 A KR20047014228 A KR 20047014228A KR 101007161 B1 KR101007161 B1 KR 101007161B1
- Authority
- KR
- South Korea
- Prior art keywords
- adapalene
- acne
- pharmaceutical composition
- treatment
- gel
- Prior art date
Links
- LZCDAPDGXCYOEH-UHFFFAOYSA-N COc(cc1)c(C2(CC(C3)C4)CC4CC3C2)cc1-c(cc1)cc(cc2)c1cc2C(O)=O Chemical compound COc(cc1)c(C2(CC(C3)C4)CC4CC3C2)cc1-c(cc1)cc(cc2)c1cc2C(O)=O LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
마지막으로, 아다팔렌은 광-손상 피부에 대하여 유익한 작용을 하는 것으로 기술된다[Photographic assessment of the effects of adapalene 0.1 and 0.3% gels and vehicle on photo-damaged skin. M. Goldfarb et al., Clinical Dermatology, Vienna, Austria, May 2000].
Claims (7)
- 생리학적으로 수용가능한 매질 내에 6-[3-(1-아다만틸)-4-메톡시페닐]-2-나프탄산(아다팔렌) 또는 그의 염을 함유하는, 염증 소인 또는 증식 소인을 가지는 여드름 치료를 위한 약학 조성물에 있어서, 조성물의 총 중량에 대하여 0.3 중량%의 아다팔렌을 함유하는 것을 특징으로 하는 조성물.
- 6-[3-(1-아다만틸)-4-메톡시페닐]-2-나프탄산(아다팔렌) 또는 그의 염을 함유하는, 통상적 여드름, 면포, 다형성 여드름, 결절낭성 여드름, 응과성 여드름, 태양에 의한, 약물-관련 또는 직업적 여드름과 같은 이차적인 여드름으로부터 선택된 염증 소인 또는 증식 소인을 가지는 여드름 치료를 위한 약학 조성물에 있어서, 조성물의 총 중량에 대하여 0.3 중량%의 아다팔렌을 함유하는 것을 특징으로 하는 약학 조성물.
- 제 2 항에 있어서, 통상적인 여드름 치료를 위한 것인 약학 조성물.
- 삭제
- 제 1 항 또는 제 2 항에 있어서, 국소 투여되는 것을 특징으로 하는 약학 조성물.
- 제 1 항 또는 제 2 항에 있어서, 상기 조성물이 젤, 로션 또는 크림의 형태인 것을 특징으로 하는 약학 조성물.
- 제 1 항 또는 제 2 항에 있어서, 하기 조성의 젤인 것을 특징으로 하는 약학 조성물:- 아다팔렌 3 mg- Carbomer 940 (BF Goodrich Carbapol 980) 11 mg- 이나트륨 에데테이트 1 mg- 메틸 파라벤 2 mg- Poloxamer 124 2 mg- 프로필렌 글리콜 40 mg- 수산화나트륨: pH 5.0 +/- 0.3를 얻기 위해 요구되는 양- 정제수 q.s. 1 g.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0203070A FR2837101B1 (fr) | 2002-03-12 | 2002-03-12 | Utilisation de l'acide 6-[1-adamantyl)-4-methoxyphenyl]-2- naphthoique pour le traitement de desordres dermatologiques |
FR0203070 | 2002-03-12 | ||
US37022302P | 2002-04-08 | 2002-04-08 | |
US60/370,223 | 2002-04-08 | ||
PCT/EP2003/003246 WO2003075908A1 (en) | 2002-03-12 | 2003-03-12 | Use of adapalene for the treatment of dermatological disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040111394A KR20040111394A (ko) | 2004-12-31 |
KR101007161B1 true KR101007161B1 (ko) | 2011-01-12 |
Family
ID=27772059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020047014228A KR101007161B1 (ko) | 2002-03-12 | 2003-03-12 | 피부병 치료를 위한 아다팔렌의 용도 |
Country Status (4)
Country | Link |
---|---|
KR (1) | KR101007161B1 (ko) |
AR (1) | AR038924A1 (ko) |
FR (1) | FR2837101B1 (ko) |
ZA (1) | ZA200405853B (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100798853B1 (ko) * | 2005-02-15 | 2008-01-28 | (주)한국스티펠 | 레티노이드를 유효성분으로 하는 백반증 예방 및 치료용 약학적 조성물 |
FR2901701B1 (fr) * | 2006-05-31 | 2010-10-29 | Galderma Res & Dev | Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations |
FR2903603B1 (fr) | 2006-07-13 | 2009-03-20 | Galderma Res & Dev S N C Snc | Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne |
EP2097076A1 (fr) * | 2006-11-20 | 2009-09-09 | Galderma Research & Development, S.N.C. | Utilisation d'adapalène pour moduler l'expression de l'il-1ra. |
EP2097075A1 (fr) * | 2006-11-20 | 2009-09-09 | Galderma Research & Development, S.N.C. | Utilisation d'adapalène pour moduler l'expression de cd1d ou il-10. |
KR20120118064A (ko) | 2010-02-09 | 2012-10-25 | 갈데르마 리써어치 앤드 디벨로프먼트 | 염증후 과다색소침착의 감소로 비코카서스인 모집단에서의 여드름 치료를 위한 아다팔렌과 벤조일 퍼옥사이드의 조합물을 포함하는 피부용 조성물 |
JP2013527161A (ja) | 2010-04-29 | 2013-06-27 | ガルデルマ・リサーチ・アンド・デヴェロップメント | アダパレン0.3%による瘢痕の処置方法 |
EP2854791A1 (en) | 2012-05-25 | 2015-04-08 | Galderma Research & Development | Treatment of preadolescent moderate acne vulgaris |
US10653659B2 (en) | 2014-11-20 | 2020-05-19 | Galderma S.A. | Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne |
KR102486502B1 (ko) * | 2015-09-15 | 2023-01-09 | 주식회사 엘지생활건강 | 여드름 치료제 전달을 위한 용해성 미세바늘 패치 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85849A1 (fr) * | 1985-04-11 | 1986-11-05 | Cird | Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques |
FR2730930B1 (fr) * | 1995-02-27 | 1997-04-04 | Oreal | Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique |
-
2002
- 2002-03-12 FR FR0203070A patent/FR2837101B1/fr not_active Expired - Fee Related
-
2003
- 2003-03-11 AR ARP030100823A patent/AR038924A1/es not_active Application Discontinuation
- 2003-03-12 KR KR1020047014228A patent/KR101007161B1/ko active IP Right Grant
-
2004
- 2004-07-22 ZA ZA200405853A patent/ZA200405853B/xx unknown
Non-Patent Citations (1)
Title |
---|
Jor. of investigative dermatology 1990, 94(5), 731-2 |
Also Published As
Publication number | Publication date |
---|---|
KR20040111394A (ko) | 2004-12-31 |
AR038924A1 (es) | 2005-02-02 |
FR2837101A1 (fr) | 2003-09-19 |
FR2837101B1 (fr) | 2004-07-02 |
ZA200405853B (en) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9872842B2 (en) | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders | |
HUT64468A (en) | Process for preparing aqueous gel composition containing retinoide | |
KR101007161B1 (ko) | 피부병 치료를 위한 아다팔렌의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131223 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181226 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20191217 Year of fee payment: 10 |